Smart hydrogel with shape memory for biomedical applications

…, T Hazama, Y Watanabe, J Gong, K Murase… - Journal of the Taiwan …, 2014 - Elsevier
The hydrogel with shape memory was synthesized and investigated for possible biomedical
science applications. The mechanical and optical properties of the chemically cross-linked …

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042)

…, T Akagami, M Arai, R Saito, D Arai, K Murase… - Lung Cancer, 2022 - Elsevier
Introduction Malignant tumors are the major cause of death in hemodialysis patients.
Management of these patients remains challenging as there is no evidence that chemotherapy is …

The efficacy and safety of long-term pirfenidone therapy in patients with idiopathic pulmonary fibrosis

…, A Miyamoto, S Hanada, Y Takahashi, K Murase… - Internal …, 2018 - jstage.jst.go.jp
Internal Medicine Vol.57 Page 1 2813 doi: 10.2169/internalmedicine.0559-17 Intern Med 57:
2813-2818, 2018 http://internmed.jp [ ORIGINAL ARTICLE ] The Efficacy and Safety of Long-term …

Clinical outcomes of second‐line chemotherapy in patients with previously treated advanced thymic carcinoma: a retrospective analysis of 191 patients from the …

…, Y Okuma, S Watanabe, S Kuyama, K Murase… - The …, 2020 - academic.oup.com
Background Because beneficial response and progression‐free survival (PFS) were
achieved by well‐designed clinical trials with tyrosine kinase inhibitors (TKIs) in patients with …

Continuous intravenous morphine infusion for severe dyspnea in terminally ill interstitial pneumonia patients

…, D Kato, Y Takahashi, K Ogawa, K Murase… - Internal …, 2016 - jstage.jst.go.jp
Objective The aims of this study were to evaluate the efficacy and safety of continuous
morphine infusion for dyspnea in patients with acute exacerbation (AE) of end-stage interstitial …

Risk factors and interventions for developing recurrent pneumonia in older adults

…, H Nakahama, S Moriguchi, K Murase… - ERJ Open …, 2023 - Eur Respiratory Soc
Background Pneumonia is common among older adults and often recurrent. Several studies
have been conducted on the risk factors for pneumonia; however, little is known about the …

OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia

K Ogawa, Y Takahashi, K Murase, S Hanada… - Respiratory …, 2018 - Elsevier
Background Pneumothorax occasionally develops in patients with interstitial pneumonia (IP)
and is often intractable. As there exists no well-established treatment for pneumothorax with …

[HTML][HTML] Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis

…, S Moriguchi, Y Takahashi, K Ogawa, K Murase… - BMC cancer, 2018 - Springer
Background Pneumatosis intestinalis (PI) is a rare complication of chemotherapy,
characterized by multiple gas accumulations within the bowel wall. Case presentation A 71-year-old …

[HTML][HTML] Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with …

…, S Moriguchi, Y Takahashi, K Ogawa, K Murase… - BMC cancer, 2019 - Springer
Background Pneumatosis intestinalis is a rare adverse event that occurs in patients with
lung cancer, especially those undergoing treatment with epidermal growth factor receptor …

Reduced area of the normal lung on high-resolution computed tomography predicts poor survival in patients with lung cancer and combined pulmonary fibrosis and …

…, S Moriguchi, Y Takahashi, K Ogawa, K Murase… - Respiratory …, 2019 - Elsevier
Background This study aimed to determine the radiologic predictors and clarify the clinical
features related to survival in patients with combined pulmonary fibrosis and emphysema (…